Connection

Co-Authors

This is a "connection" page, showing publications co-authored by QIZHI YAO and WILLIAM FISHER.
Connection Strength

2.036
  1. Nanoparticle-Mediated Therapy with miR-198 Sensitizes Pancreatic Cancer to Gemcitabine Treatment through Downregulation of VCP-Mediated Autophagy. Pharmaceutics. 2023 Jul 28; 15(8).
    View in: PubMed
    Score: 0.238
  2. Overexpression of Semaphorin-3E enhances pancreatic cancer cell growth and associates with poor patient survival. Oncotarget. 2016 Dec 27; 7(52):87431-87448.
    View in: PubMed
    Score: 0.151
  3. A tumorigenic factor interactome connected through tumor suppressor microRNA-198 in human pancreatic cancer. Clin Cancer Res. 2013 Nov 01; 19(21):5901-13.
    View in: PubMed
    Score: 0.120
  4. Down-regulation of ZIP4 by RNA interference inhibits pancreatic cancer growth and increases the survival of nude mice with pancreatic cancer xenografts. Clin Cancer Res. 2009 Oct 01; 15(19):5993-6001.
    View in: PubMed
    Score: 0.091
  5. Thymosin beta-10 is aberrantly expressed in pancreatic cancer and induces JNK activation. Cancer Invest. 2009 Mar; 27(3):251-6.
    View in: PubMed
    Score: 0.088
  6. Somatostatin receptor-1 induces cell cycle arrest and inhibits tumor growth in pancreatic cancer. Cancer Sci. 2008 Nov; 99(11):2218-23.
    View in: PubMed
    Score: 0.085
  7. Interleukin-8 increases vascular endothelial growth factor and neuropilin expression and stimulates ERK activation in human pancreatic cancer. Cancer Sci. 2008 Apr; 99(4):733-7.
    View in: PubMed
    Score: 0.082
  8. Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancer. Mol Cancer Ther. 2008 Feb; 7(2):286-96.
    View in: PubMed
    Score: 0.081
  9. Aberrant expression of zinc transporter ZIP4 (SLC39A4) significantly contributes to human pancreatic cancer pathogenesis and progression. Proc Natl Acad Sci U S A. 2007 Nov 20; 104(47):18636-41.
    View in: PubMed
    Score: 0.080
  10. Thymosinalpha1 stimulates cell proliferation by activating ERK1/2, JNK, and increasing cytokine secretion in human pancreatic cancer cells. Cancer Lett. 2007 Apr 08; 248(1):58-67.
    View in: PubMed
    Score: 0.073
  11. Cyclophilin A is overexpressed in human pancreatic cancer cells and stimulates cell proliferation through CD147. Cancer. 2006 May 15; 106(10):2284-94.
    View in: PubMed
    Score: 0.072
  12. Effect of cyclophilin A on gene expression in human pancreatic cancer cells. Am J Surg. 2005 Nov; 190(5):739-45.
    View in: PubMed
    Score: 0.070
  13. Transfection of SSTR-1 and SSTR-2 inhibits Panc-1 cell proliferation and renders Panc-1 cells responsive to somatostatin analogue. J Am Coll Surg. 2005 Oct; 201(4):571-8.
    View in: PubMed
    Score: 0.069
  14. Signal transduction in human pancreatic cancer: roles of transforming growth factor beta, somatostatin receptors, and other signal intermediates. Arch Immunol Ther Exp (Warsz). 2005 Sep-Oct; 53(5):381-7.
    View in: PubMed
    Score: 0.069
  15. Gene overexpression in pancreatic adenocarcinoma: diagnostic and therapeutic implications. World J Surg. 2005 Mar; 29(3):297-305.
    View in: PubMed
    Score: 0.066
  16. Roles of neuropilins in neuronal development, angiogenesis, and cancers. World J Surg. 2005 Mar; 29(3):271-5.
    View in: PubMed
    Score: 0.066
  17. New roles of a neuropeptide cortistatin in the immune system and cancer. World J Surg. 2005 Mar; 29(3):354-6.
    View in: PubMed
    Score: 0.066
  18. Roles of thymosins in cancers and other organ systems. World J Surg. 2005 Mar; 29(3):264-70.
    View in: PubMed
    Score: 0.066
  19. Somatostatin, somatostatin receptors, and pancreatic cancer. World J Surg. 2005 Mar; 29(3):293-6.
    View in: PubMed
    Score: 0.066
  20. Roles of cyclophilins in cancers and other organ systems. World J Surg. 2005 Mar; 29(3):276-80.
    View in: PubMed
    Score: 0.066
  21. Characterization of somatostatin receptor expression in human pancreatic cancer using real-time RT-PCR. J Surg Res. 2004 Jun 15; 119(2):130-7.
    View in: PubMed
    Score: 0.063
  22. Microbiome changes associated with acute and chronic pancreatitis: A systematic review. Pancreatology. 2021 Jan; 21(1):1-14.
    View in: PubMed
    Score: 0.050
  23. Chemo-immunotherapy mediates durable cure of orthotopic KrasG12D/p53-/- pancreatic ductal adenocarcinoma. Oncoimmunology. 2016; 5(9):e1213933.
    View in: PubMed
    Score: 0.037
  24. A novel epigenetic CREB-miR-373 axis mediates ZIP4-induced pancreatic cancer growth. EMBO Mol Med. 2013 Sep; 5(9):1322-34.
    View in: PubMed
    Score: 0.030
  25. Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis. World J Surg. 2009 Apr; 33(4):698-709.
    View in: PubMed
    Score: 0.022
  26. Thymosin Beta 4 is overexpressed in human pancreatic cancer cells and stimulates proinflammatory cytokine secretion and JNK activation. Cancer Biol Ther. 2008 Mar; 7(3):419-23.
    View in: PubMed
    Score: 0.020
  27. Current update of cytokines in pancreatic cancer: pathogenic mechanisms, clinical indication, and therapeutic values. Cancer Invest. 2006 Nov; 24(7):696-703.
    View in: PubMed
    Score: 0.019
  28. Pancreatic carcinoma cells express neuropilins and vascular endothelial growth factor, but not vascular endothelial growth factor receptors. Cancer. 2004 Nov 15; 101(10):2341-50.
    View in: PubMed
    Score: 0.016
  29. Somatostatin receptor gene transfer inhibits established pancreatic cancer xenografts. J Surg Res. 2003 Nov; 115(1):41-7.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.